References – Do Probiotics Help
Regardless of methods primarily based on social distancing, hygiene, and screening, COVID-19 is progressing quickly all through the world, with healthcare techniques prone to being overwhelmed. Whereas identification of efficient drug therapies is ongoing, vaccines is not going to be obtainable within the close to future. Due to this fact, further preventive methods are urgently wanted.
COVID-19 presents with a spectrum of illness severity, starting from gentle and non-specific flu-like signs, to pneumonia, and life-threatening issues resembling acute respiratory misery syndrome (ARDS) and a number of organ failure. Whereas transmission of SARS-CoV-2 is assumed to happen primarily by way of respiratory droplets, the intestine may contribute towards the pathogenesis of COVID-19 (1). SARS-CoV-2 RNA has been detected within the gastrointestinal tract and stool samples from sufferers (2–4), and in sewage techniques (5). Coronaviruses, together with SARS-Cov-2 can invade enterocytes, thereby appearing as a reservoir for the virus (4). Certainly, giant scientific research from China point out that gastrointestinal signs are frequent in COVID-19, and are related to illness severity (3, 4).
Probiotics are reside microorganisms that when administered in enough quantities confer a well being profit on the host (6). Scientific proof exhibits that sure probiotic strains assist to stop bacterial and viral infections, together with gastroenteritis, sepsis, and respiratory tract infections (RTIs). The explanation for including probiotic strains to the general prevention and care technique is based in science and scientific research, albeit hitherto none immediately on the etiological agent of this pandemic.
Scientific Knowledge Supporting the Use of Probiotics to Forestall Covid-19
Probiotics can stop antibiotic-associated diarrhea, and infections within the gastrointestinal tract, but additionally infections at different websites, together with sepsis, and RTIs (7–13). Meta-analyses are the gold customary for evidence-based drugs. In a single evaluation of greater than 8,000 preterm infants included in randomized management trials (RCTs), sufferers receiving enteral supplementation with probiotics confirmed a discount in necrotizing enterocolitis, nosocomial sepsis, and all-cause mortality (14). A well-conducted RCT together with >4,000 newborns in India discovered a discount in sepsis and decrease RTIs in infants handled with a pressure of Lactobacillus plantarum mixed with prebiotics (that are development substrates particular for useful microorganisms) (15).
Viruses are etiologic brokers of over 90% of higher RTIs. The optimistic impression of probiotics on prevention of higher RTIs is documented in a lot of research. A meta-analysis of 12 RCTs together with 3,720 adults and kids reported a 2-fold decrease danger of growing higher RTI in topics taking probiotics, and a small however vital discount in illness severity in these contaminated. A randomized, double-blind, placebo-controlled intervention research of 479 adults confirmed that Lactobacillus gasseri PA 16/8, Bifidobacterium longum SP 07/3, and Bifidobacterium bifidum MF 20/5 with nutritional vitamins and minerals lowered not solely the length of frequent chilly episodes but additionally days with fever (16). The impression of probiotics on prevention of higher RTIs attributable to particular viruses has additionally been documented. An RCT together with 94 preterm infants confirmed that galacto-oligosaccharide and polydextrose prebiotic combination (1:1), or probiotic Lactobacillus rhamnosus GG given between 3 and 60 days of life lowered the incidence of clinically outlined virus-associated RTI by 2- to 3-fold in comparison with placebo (17). The incidence of rhinovirus-associated episodes, which comprised 80% of all RTIs on this research, was additionally strongly diminished with probiotics or prebiotics. The incidence of influenza RTI was diminished following consumption of Lactobacillus brevis in an open label research of 1,783 faculty youngsters (18). Pertinent to the pandemic affecting adults greater than youngsters, these optimistic findings had been confirmed in an RCT that included 27 aged topics receiving Bifidobacterium longum or placebo (19). Moreover, lactic acid micro organism, from which many probiotics are chosen, are a part of the higher respiratory tract microbiota in wholesome individuals, and a few strains are being thought-about for prevention of recurrent otitis media (20, 21). This makes their use for contributing to decelerate development of the coronavirus pandemic worthy of consideration.
Probiotics have additionally been used to stop bacterial decrease RTIs in critically ailing adults. Meta-analyses of RCTs together with near 2,000 sufferers discovered that probiotic strains scale back the incidence of ventilator-associated pneumonia (22, 23). However low high quality of proof and conflicting outcomes amongst totally different research calls for added well-conducted RCTs.
It must be famous that not all probiotics, even these with gastrointestinal advantages, essentially contribute in each approach to lowering the chance of respiratory an infection. For instance, Lactobacillus rhamnosus GG and Bifidobacterium animalis ssp. lactis could contribute to intestinal advantages, however don’t scale back the variety of viruses within the nasopharynx (24). Examples of merchandise that may very well be thought-about, relying on availability in a given nation, are offered in Desk 1.
TABLE 1
Desk 1. The next are examples (not unique) of probiotic merchandise, or internet sites itemizing merchandise, with documentation in human research which will have relevance to lowering the burden of the coronavirus pandemic.
Mechanistic Foundation for the Motion of Probiotics to Forestall Infections and Relevance to Covid-19
Mechanisms that may clarify scientific success of probiotics embrace enhancement of the intestinal epithelial barrier, competitors with pathogens for vitamins and adhesion to the intestinal epithelium, manufacturing of anti-microbial substances and modulation of the host immune system (28). An RCT of 55 infants confirmed that enteral supplementation with a mixture of Bifidobacterium bifidum and Streptococcus thermophilus diminished the incidence of diarrhea and shedding of rotaviruses (29), an impact that has been confirmed in subsequent research (30). This is able to point out interference with viral entry into cells and/or inhibition of viral replication within the gut. Whereas this mechanism could have a job in lowering dissemination of coronavirus by way of the intestine, the probiotic strains weren’t administered to the respiratory tract. So, direct inhibition could seem not possible at this web site. Having mentioned that, lungs have their very own microbiota and a gut-lung connection has been described whereby host-microbe, microbe-microbe and immune interactions can affect the course of respiratory ailments (31). RTIs resembling influenza are related to an imbalance within the microbial communities of the respiratory and gastrointestinal tracts (32, 33). This dysbiosis could alter subsequent immune perform and predispose to secondary bacterial an infection. As studies from China point out that COVID-19 is likely to be related to intestinal dysbiosis inflicting irritation and poorer response to pathogens (34, 35), the case exists for probiotic strains that restore intestine homeostasis (36). It’s possible that orally administered probiotic strains might additional affect this gut-lung axis, as some can migrate from the intestine to distant websites, such because the breast to deal with mastitis (37).
The intestine microbiome has a essential impression on systemic immune responses, and immune responses at distant mucosal websites, together with the lungs (38, 39). Administration of sure bifidobacteria or lactobacilli has useful impression on influenza virus clearance from the respiratory tract (39, 40). Probiotic strains enhance ranges of kind I interferons, improve the quantity and exercise of antigen presenting cells, NK cells, T cells, in addition to the degrees of systemic and mucosal particular antibodies within the lungs (16, 19, 39). There may be additionally proof that probiotic strains modify the dynamic stability between proinflammatory and immunoregulatory cytokines that permit viral clearance whereas minimizing immune response-mediated injury to the lungs. This is likely to be significantly related to stop ARDS, a significant complication of COVID-19. An RCT with Lactobacillus plantarum DR7 confirmed suppression of plasma pro-inflammatory cytokines (IFN-γ, TNF-α) in middle-aged adults, and enhancement of anti-inflammatory cytokines (IL-4, IL-10) in younger adults, together with diminished plasma peroxidation and oxidative stress ranges (25). Given the cytokine storm that seems to happen in lots of COVID-19 sufferers, such a modulation could show to be essential. The style during which orally administered probiotic strains contributes to this seems to contain the immune response emanating from the gut, a focus of the physique’s defenses. Due to this fact, probiotic strains documented to boost the integrity of tight junctions, for instance by means of rising butyrate, a gas for colonocytes might theoretically scale back SARS-Cov-2 invasion.
Proof for antiviral exercise of probiotic strains towards frequent respiratory viruses, together with influenza, rhinovirus, and respiratory syncytial virus comes from scientific and experimental research (17–19, 41). Whereas none of those results or mechanisms have been examined on the brand new SARS-CoV-2 virus, this could not negate contemplating this method, particularly when results of probiotics towards different coronavirus strains have been reported (42–45). Moreover, sufferers are dying from secondary bacterial infections. A latest research in mice has proven that oral administration of Lactobacillus acidophilus CMCC878, began 24 h after pulmonary inoculation of Pseudomonas aeruginosa and Staphylococcus aureus diminished bacterial load within the lungs, and decreased lung injury and systemic irritation (46).
Security of Probiotics
Probiotics are typically protected, even in essentially the most susceptible populations and in intensive care settings (14, 47). Circumstances of probiotic-associated bacteremia and fungaemia have occurred on extraordinarily uncommon events, primarily in untimely and immunocompromised sufferers handled with preparations missing enough high quality management (48, 49). Reasonably than take into account intensive care sufferers too ailing to obtain probiotic and prebiotic remedy, RCTs of probiotics for the prevention of ventilator-associated pneumonia present a motive to contemplate them (22, 23, 26). Furthermore, in an RCT of 65 critically ailing, mechanically ventilated, a number of trauma sufferers, the synbiotic Pediococcus pentosaceus 5-33:3, Leuconostoc mesenteroides 32-77:1, L. paracasei ssp. paracasei 19, L. plantarum 2,362 plus inulin, oat bran, pectin, and resistant starch resulted in diminished charge of infections, systemic inflammatory response syndrome, sepsis, days of keep within the intensive care unit, days below mechanical air flow, and mortality (27).
Abstract
In abstract, orally administered probiotic strains can scale back the incidence and severity of viral RTIs. At a time when docs are utilizing medicine with little anti- COVID-19 knowledge, probiotic strains documented for anti-viral and respiratory actions (not low-quality undocumented imitations) ought to turn out to be a part of the armamentarium to cut back the burden and severity of this pandemic. Authorities funding is getting used to check quite a few medicine however simply as vital, they need to fund probiotic trials. As well as, use of acknowledged prebiotics (e.g., fructans, galactans) to boost propagation of probiotic strains and indigenous useful microbes must be really useful as a part of the general technique to flatten the curve (11, 50).
Creator Contributions
EG, DB, and VD contributed conception of the manuscript. EG and VD wrote the primary draft. DB, GG, and GR wrote sections of the manuscript. All authors contributed to manuscript revision, learn, and authorized the submitted model.
Funding
EG is supported by the Leenaards Basis.
Battle of Curiosity
GG and GR present recommendation to probiotic and prebiotic firms.
The remaining authors declare that the analysis was carried out within the absence of any industrial or monetary relationships that may very well be construed as a possible battle of curiosity.
References
3. Jin X, Lian JS, Hu JH, Gao J, Zheng L, Zhang YM, et al. Epidemiological, scientific and virological traits of 74 instances of coronavirus-infected illness 2019 (COVID-19) with gastrointestinal signs. Intestine. (2020). doi: 10.1136/gutjnl-2020-320926. [Epub ahead of print]. PubMed Summary | CrossRef Full Textual content | Google Scholar
4. Lin L, Jiang X, Zhang Z, Huang S, Zhang Z, Fang Z, et al. Gastrointestinal signs of 95 instances with SARS-CoV-2 an infection. Intestine. (2020). doi: 10.1136/gutjnl-2020-321013. [Epub ahead of print]. PubMed Summary | CrossRef Full Textual content | Google Scholar
5. Wu F, Xiao A, Zhang J, Gu X, Lee WL, Kauffman Okay, et al. SARS-CoV-2 titers in wastewater are larger than anticipated from clinically confirmed instances. medRxiv. (2020). doi: 10.1101/2020.04.05.20051540. [Epub ahead of print]. CrossRef Full Textual content | Google Scholar
6. Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, et al. Professional consensus doc. The Worldwide Scientific Affiliation for Probiotics and Prebiotics consensus assertion on the scope and applicable use of the time period probiotic. Nat Rev Gastroenterol Hepatol. (2014) 11:506–14. doi: 10.1038/nrgastro.2014.66 PubMed Summary | CrossRef Full Textual content | Google Scholar
7. Szajewska H, Kolodziej M, Gieruszczak-Bialek D, Skorka A, Ruszczynski M, Shamir R. Systematic evaluation with meta-analysis: Lactobacillus rhamnosus GG for treating acute gastroenteritis in youngsters–a 2019 replace. Aliment Pharmacol Ther. (2019) 49:1376–84. doi: 10.1111/apt.15267 PubMed Summary | CrossRef Full Textual content | Google Scholar
8. Goldenberg JZ, Yap C, Lytvyn L, Lo CK, Beardsley J, Mertz D, et al. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and kids. Cochrane Database Syst Rev. (2017) 12:CD006095. doi: 10.1002/14651858.CD006095.pub4 PubMed Summary | CrossRef Full Textual content | Google Scholar
9. Guo Q, Goldenberg JZ, Humphrey C, El Dib R, Johnston BC. Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database Syst Rev. (2019) 4:CD004827. doi: 10.1002/14651858.CD004827.pub5 PubMed Summary | CrossRef Full Textual content | Google Scholar
10. Lenoir-Wijnkoop I, Gerlier L, Roy D, Reid G. The scientific and financial impression of probiotics consumption on respiratory tract infections: projections for Canada. PLoS ONE. (2016) 11:e0166232. doi: 10.1371/journal.pone.0166232 PubMed Summary | CrossRef Full Textual content | Google Scholar
11. Pregliasco F, Anselmi G, Fonte L, Giussani F, Schieppati S, Soletti L. A brand new probability of stopping winter ailments by the administration of synbiotic formulations. J Clin Gastroenterol. (2008) 42(Suppl.3):S224–33. doi: 10.1097/MCG.0b013e31817e1c91 PubMed Summary | CrossRef Full Textual content | Google Scholar
12. Guillemard E, Tondu F, Lacoin F, Schrezenmeir J. Consumption of a fermented dairy product containing the probiotic Lactobacillus casei DN-114001 reduces the length of respiratory infections within the aged in a randomised managed trial. Br J Nutr. (2010) 103:58–68. doi: 10.1017/S0007114509991395 PubMed Summary | CrossRef Full Textual content | Google Scholar
13. Guillemard E, Tanguy J, Flavigny A, de la Motte S, Schrezenmeir J. Results of consumption of a fermented dairy product containing the probiotic Lactobacillus casei DN-114 001 on frequent respiratory and gastrointestinal infections in shift employees in a randomized managed trial. J Am Coll Nutr. (2010) 29:455–68. doi: 10.1080/07315724.2010.10719882 PubMed Summary | CrossRef Full Textual content | Google Scholar
14. Dermyshi E, Wang Y, Yan C, Hong W, Qiu G, Gong X, et al. The “golden age” of probiotics: a scientific evaluation and meta-analysis of randomized and observational research in preterm infants. Neonatology. (2017) 112:9–23. doi: 10.1159/000454668 PubMed Summary | CrossRef Full Textual content | Google Scholar
15. Panigrahi P, Parida S, Nanda NC, Satpathy R, Pradhan L, Chandel DS, et al. A randomized synbiotic trial to stop sepsis amongst infants in rural India. Nature. (2017) 548:407–12. doi: 10.1038/nature23480 PubMed Summary | CrossRef Full Textual content | Google Scholar
16. de Vrese M, Winkler P, Rautenberg P, Tougher T, Noah C, Laue C, et al. Impact of Lactobacillus gasseri PA 16/8, Bifidobacterium longum SP 07/3, B. bifidum MF 20/5 on frequent chilly episodes: a double blind, randomized, managed trial. Clin Nutr. (2005) 24:481–91. doi: 10.1016/j.clnu.2005.02.006 PubMed Summary | CrossRef Full Textual content | Google Scholar
17. Luoto R, Ruuskanen O, Waris M, Kalliomaki M, Salminen S, Isolauri E. Prebiotic and probiotic supplementation prevents rhinovirus infections in preterm infants: a randomized, placebo-controlled trial. J Allergy Clin Immunol. (2014) 133:405–13. doi: 10.1016/j.jaci.2013.08.020 PubMed Summary | CrossRef Full Textual content | Google Scholar
18. Waki N, Matsumoto M, Fukui Y, Suganuma H. Results of probiotic Lactobacillus brevis KB290 on incidence of influenza an infection amongst schoolchildren: an open-label pilot research. Lett Appl Microbiol. (2014) 59:565–71. doi: 10.1111/lam.12340 PubMed Summary | CrossRef Full Textual content | Google Scholar
19. Namba Okay, Hatano M, Yaeshima T, Takase M, Suzuki Okay. Results of Bifidobacterium longum BB536 administration on influenza an infection, influenza vaccine antibody titer, and cell-mediated immunity within the aged. Biosci Biotechnol Biochem. (2010) 74:939–45. doi: 10.1271/bbb.90749 PubMed Summary | CrossRef Full Textual content | Google Scholar
20. Rautava S, Salminen S, Isolauri E. Particular probiotics in lowering the chance of acute infections in infancy–a randomised, double-blind, placebo-controlled research. Br J Nutr. (2009) 101:1722–6. doi: 10.1017/S0007114508116282 PubMed Summary | CrossRef Full Textual content | Google Scholar
21. Cardenas N, Martin V, Arroyo R, López M, Carrera M, Badiola C, et al. Prevention of recurrent acute otitis media in youngsters by means of the usage of Lactobacillus salivarius PS7, a target-specific probiotic pressure. Vitamins. (2019) 11:e376. doi: 10.3390/nu11020376 PubMed Summary | CrossRef Full Textual content | Google Scholar
22. Bo L, Li J, Tao T, Bai Y, Ye X, Hotchkiss RS, et al. Probiotics for stopping ventilator-associated pneumonia. Cochrane Database Syst Rev. (2014) 10:CD009066. doi: 10.1002/14651858.CD009066.pub2 CrossRef Full Textual content | Google Scholar
23. Su M, Jia Y, Li Y, Zhou D, Jia J. Probiotics for the prevention of ventilator-associated pneumonia: a meta-analysis of randomized managed trials. Respir Care. (2020) 65:5. doi: 10.4187/respcare.07097. [Epub ahead of print]. PubMed Summary | CrossRef Full Textual content | Google Scholar
24. Lehtoranta L, Kalima Okay, He L, Lappalainen M, Roivainen M, Närkiö M, et al. Particular probiotics and virological findings in symptomatic conscripts attending navy service in Finland. J Clin Virol. (2014) 60:276–81. doi: 10.1016/j.jcv.2014.03.021 PubMed Summary | CrossRef Full Textual content | Google Scholar
25. Chong HX, Yusoff NAA, Hor YY, Lew LC, Jaafar MH, Choi SB, et al. Lactobacillus plantarum DR7 improved higher respiratory tract infections by way of enhancing immune and inflammatory parameters: a randomized, double-blind, placebo-controlled research. J Dairy Sci. (2019) 102:4783–97. doi: 10.3168/jds.2018-16103 PubMed Summary | CrossRef Full Textual content | Google Scholar
26. Shimizu Okay, Yamada T, Ogura H, Mohri T, Kiguchi T, Fujimi S, et al. Synbiotics modulate intestine microbiota and scale back enteritis and ventilator-associated pneumonia in sufferers with sepsis: a randomized managed trial. Crit Care. (2018) 22:239. doi: 10.1186/s13054-018-2167-x PubMed Summary | CrossRef Full Textual content | Google Scholar
27. Kotzampassi Okay, Giamarellos-Bourboulis EJ, Voudouris A, Kazamias P, Eleftheriadis E. Advantages of a synbiotic components (Synbiotic 2000Forte) in critically Ailing trauma sufferers: early outcomes of a randomized managed trial. World J Surg. (2006) 30:1848–55. doi: 10.1007/s00268-005-0653-1 PubMed Summary | CrossRef Full Textual content | Google Scholar
29. Saavedra JM, Bauman NA, Oung I, Perman JA, Yolken RH. Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus. Lancet. (1994) 344:1046–9. doi: 10.1016/S0140-6736(94)91708-6 PubMed Summary | CrossRef Full Textual content | Google Scholar
31. Enaud R, Prevel R, Ciarlo E, Beaufils F, Wieërs G, Guery B, et al. The gut-lung axis in well being and respiratory ailments: a spot for inter-organ and inter-kingdom crosstalks. Entrance Cell Infect Microbiol. (2020) 10:9. doi: 10.3389/fcimb.2020.00009 PubMed Summary | CrossRef Full Textual content | Google Scholar
32. Sencio V, Barthelemy A, Tavares LP, Machado MG, Soulard D, Cuinat C, et al. Intestine dysbiosis throughout influenza contributes to pulmonary pneumococcal superinfection by means of altered short-chain fatty acid manufacturing. Cell Rep. (2020) 30:2934–47 e6. doi: 10.1016/j.celrep.2020.02.013 PubMed Summary | CrossRef Full Textual content | Google Scholar
34. Gao QY, Chen YX, Fang JY. 2019 Novel coronavirus an infection and gastrointestinal tract. J Dig Dis. (2020) 12:3. doi: 10.1111/1751-2980.12851 CrossRef Full Textual content | Google Scholar
35. Xu Okay, Cai H, Shen Y, Ni Q, Chen Y, Hu S, et al. Administration of corona virus disease-19 (COVID-19): the Zhejiang expertise. Zhejiang Da Xue Xue Bao Yi Xue Ban. (2020) 49. PubMed Summary | Google Scholar
36. Di Pierro F. A potential probiotic (S. salivarius K12) method to enhance oral and lung microbiotas and lift defenses towards SARS-CoV-2. Minerva Med. (2020). doi: 10.23736/S0026-4806.20.06570-2. [Epub ahead of print]. PubMed Summary | CrossRef Full Textual content | Google Scholar
37. Arroyo R, Martin V, Maldonado A, Jimenez E, Fernandez L, Rodriguez JM. Therapy of infectious mastitis throughout lactation: antibiotics versus oral administration of lactobacilli remoted from breast milk. Clin Infect Dis. (2010) 50:1551–8. doi: 10.1086/652763 PubMed Summary | CrossRef Full Textual content | Google Scholar
38. Abt MC, Osborne LC, Monticelli LA, Doering TA, Alenghat T, Sonnenberg GF, et al. Commensal micro organism calibrate the activation threshold of innate antiviral immunity. Immunity. (2012) 37:158–70. doi: 10.1016/j.immuni.2012.04.011 PubMed Summary | CrossRef Full Textual content | Google Scholar
39. Zelaya H, Alvarez S, Kitazawa H, Villena J. Respiratory antiviral immunity and immunobiotics: useful results on inflammation-coagulation interplay throughout influenza virus an infection. Entrance Immunol. (2016) 7:633. doi: 10.3389/fimmu.2016.00633 PubMed Summary | CrossRef Full Textual content | Google Scholar
40. Ichinohe T, Pang IK, Kumamoto Y, Peaper DR, Ho JH, Murray TS, et al. Microbiota regulates immune protection towards respiratory tract influenza A virus an infection. Proc Natl Acad Sci USA. (2011) 108:5354–9. doi: 10.1073/pnas.1019378108 PubMed Summary | CrossRef Full Textual content | Google Scholar
41. Turner RB, Woodfolk JA, Borish L, Steinke JW, Patrie JT, Muehling LM, et al. Impact of probiotic on innate inflammatory response and viral shedding in experimental rhinovirus an infection–a randomised managed trial. Benef Microbes. (2017) 8:207–15. doi: 10.3920/BM2016.0160 PubMed Summary | CrossRef Full Textual content | Google Scholar
42. Kumar R, Search engine optimization BJ, Mun MR, Kim CJ, Lee I, Kim H, et al. Putative probiotic Lactobacillus spp. from porcine gastrointestinal tract inhibit transmissible gastroenteritis coronavirus and enteric bacterial pathogens. Trop Anim Well being Prod. (2010) 42:1855–60. doi: 10.1007/s11250-010-9648-5 PubMed Summary | CrossRef Full Textual content | Google Scholar
43. Chai W, Burwinkel M, Wang Z, Palissa C, Esch B, Twardziok S, et al. Antiviral results of a probiotic Enterococcus faecium pressure towards transmissible gastroenteritis coronavirus. Arch Virol. (2013) 158:799–807. doi: 10.1007/s00705-012-1543-0 PubMed Summary | CrossRef Full Textual content | Google Scholar
44. Liu YS, Liu Q, Jiang YL, Yang WT, Huang HB, Shi CW, et al. Floor-displayed porcine IFN-lambda3 in Lactobacillus plantarum inhibits porcine enteric coronavirus an infection of porcine intestinal epithelial cells. J Microbiol Biotechnol. (2019) 30:515–525. doi: 10.4014/jmb.1909.09041. [Epub ahead of print]. PubMed Summary | CrossRef Full Textual content | Google Scholar
45. Wang Okay, Ran L, Yan T, Niu Z, Kan Z, Zhang Y, et al. Anti-TGEV miller pressure an infection impact of Lactobacillus plantarum supernatant primarily based on the JAK-STAT1 signaling pathway. Entrance Microbiol. (2019) 10:2540. doi: 10.3389/fmicb.2019.02540 PubMed Summary | CrossRef Full Textual content | Google Scholar
46. Shoaib A, Xin L, Xin Y. Oral administration of Lactobacillus acidophilus alleviates exacerbations in Pseudomonas aeruginosa and Staphylococcus aureus pulmonary infections. Pak J Pharm Sci. (2019) 32:1621–30. PubMed Summary | Google Scholar
47. Sanders ME, Merenstein DJ, Ouwehand AC, Reid G, Salminen S, Cabana MD, et al. Probiotic use in at-risk populations. J Am Pharm Assoc. (2016) 56:680–6. doi: 10.1016/j.japh.2016.07.001 PubMed Summary | CrossRef Full Textual content | Google Scholar
48. Bertelli C, Pillonel T, Torregrossa A, Simonsen GS, Støen R, Klingenberg C. Bifidobacterium longum bacteremia in preterm infants receiving probiotics. Clin Infect Dis. (2015) 60:924–7. doi: 10.1093/cid/ciu946 PubMed Summary | CrossRef Full Textual content | Google Scholar
49. Kolacek S, Hojsak I, Berni Canani R, Guarino A, Indrio F, Orel R, et al. Industrial probiotic merchandise: a name for improved high quality management. A place paper by the ESPGHAN Working Group for Probiotics and Prebiotics. J Pediatric Gastroenterol Nutr. (2017) 65:117–24. doi: 10.1097/MPG.0000000000001603 PubMed Summary | CrossRef Full Textual content | Google Scholar